| Literature DB >> 26293676 |
Nisreen Amayiri1, Maysa Al-Hussaini2, Maisa Swaidan3, Imad Jaradat4, Monther Qandeel3, Uri Tabori5, Cynthia Hawkins6, Awni Musharbash7, Khulood Alsaad8, Eric Bouffet5.
Abstract
Synchronous primary malignant brain tumors are rare. We present a 5-year-old boy with synchronous glioblastoma and medulloblastoma. Both tumor samples had positive p53 stain and loss of PMS2 and MLH1 stains. The child had multiple café au lait spots and a significant family history of cancer. After subtotal resection of both tumors, he received craniospinal radiation with concomitant temozolomide followed by chemotherapy, alternating cycles of cisplatin/lomustine/vincristine with temozolomide. Then, he started maintenance treatment with cis-retinoic acid (100 mg/m(2)/day for 21 days). He remained asymptomatic for 34 months despite a follow-up brain MRI consistent with glioblastoma relapse 9 months before his death. Cis-retinoic acid may have contributed to prolong survival in this child with a probable biallelic mismatch repair syndrome.Entities:
Keywords: Biallelic mismatch repair syndrome; Cis-retinoic acid; Glioblastoma; Synchronous tumors
Mesh:
Substances:
Year: 2015 PMID: 26293676 DOI: 10.1007/s00381-015-2883-3
Source DB: PubMed Journal: Childs Nerv Syst ISSN: 0256-7040 Impact factor: 1.475